Japan· JP-2190408A2034
アルガトロバン水和物
A argatroban product containing アルガトロバン水和物, registered in Japan by 田辺ファーマ, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Argatroban is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AE03 (argatroban), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 5 of them publish a price we can compare per daily dose
Argatroban · ATC B01AE03
11 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アルガトロバン水和物
- Manufacturer
- 田辺ファーマ
- Country
- Japan (JP)
- ATC code
- B01AE03
- ATC class
- Argatroban
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for argatroban.
Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Argatroban · interactions on record
158 records
- 72 severe
- 81 moderate
- 5 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AE03
Argatroban, as other registers publish it.
- FranceARGANOVA 1 mg/mL, solution pour perfusionETHYPHARM
- FranceARGANOVA 100 mg/mL, solution à diluer pour perfusion en multidoseETHYPHARM
- NetherlandsArganova Multidose 100 mg/ml concentraat voor oplossing voor infusieEthypharm
- NetherlandsArganova Multidose 100mg/ml concentraat voor oplossing voor infusieBModesto B.V.
- GermanyArgatraEthypharm
- SwitzerlandArgatra 100mg/ml, Konzentrat zur Herstellung einer InfusionslösungMedius AG
- SwitzerlandArgatra 100mg/ml, Konzentrat zur Herstellung einer InfusionslösungMedius AG
- GermanyArgatra MultidoseEthypharm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e74bd0f0-bbc2-44a7-9eed-a38fb0a2bd32 GET /v1/drugs/e74bd0f0-bbc2-44a7-9eed-a38fb0a2bd32?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ２ｍＬ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2190408A2034",
"category": "注射薬",
"price_yen": 1205,
"generic_name": "アルガトロバン水和物",
"product_name_jp": null,
"therapeutic_class": "2190",
"transitional_expiry": null
}See everything about argatroban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.